Review of the properties and mechanisms of action of cyclosporine with an emphasis on dermatological therapy in dogs, cats and people

Veterinary Record

Volumn 152, Issue 25, 2003, Pages 768-772

  Robson, D ^a  

^a Melbourne Veterinary Referral Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; CYCLOOXYGENASE 2; CYCLOPHILIN; CYCLOSPORIN; CYCLOSPORIN A; CYCLOSPORIN DERIVATIVE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; LEUKOTRIENE B4; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PROLACTIN; RAPAMYCIN; STEM CELL FACTOR RECEPTOR; TACROLIMUS; THROMBOXANE SYNTHASE; TRANSCRIPTION FACTOR NFAT;

ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; CAT DISEASE; DOG DISEASE; DOWN REGULATION; DRUG MECHANISM; DRUG POTENCY; DRUG USE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LACRIMATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PARASITOSIS; REVIEW; SKIN DISEASE; T LYMPHOCYTE; VETERINARY MEDICINE;

CANIS FAMILIARIS; FELIS CATUS;

EID: 0038081378     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.152.25.768     Document Type: Review

References (47)

1. ABBAS, A. K., LICHTMAN, A. H.&POBER, J. S. (1997) Cellular and Molecular Immunology. 3rd edn. Philadelphia, W. B. Saunders. p 166
2. 2 production. Inflammation Research 49, 20-26
3. BERNSTEEN, L., GREGORY, C. R., ARONSON, L. R., LIRTZMAN, R. A.&BRUMMER, D. G. (1999) Acute toxoplasmosis following renal transplantation in three cats and a dog. Journal of the American Veterinary Medical Association 215, 1123-1126
4. CACALANO, N. A., CHEN, B. X., CLEVELAND, W. L.&ERLANGER, B. F. (1992) Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 89, 4353-4357
5. CASWELL, A. (1999) E-MIMs 4.0 St Leonards, MIMS Australia
6. CHAPPELL, L. H.&WASTLING, J. M. (1992) Cyclosporin A: antiparasite drug, modulator of the host-parasite relationship and immunosuppressant. Parasitology 105 (Suppl), S25-S40
7. CIRILLO, R., TRIGGIANI, M., SIRI, L., CICCARELLI, A., PETTIT, G. R. CONDORELLI, M.&MARONE, G. (1990) Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. Journal of Immunology 144, 3891-3897
8. COCKERILL, G. W., BERT, A. G., RYAN, G. R., GAMBLE, J. R., VADAS, M. A.&COCKERILL, P. N. (1995) Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T cell transcription factor NFAT. Blood 86, 2689-2698
9. DE PAULIS, A., CICCARELLI, A., MARINO, I., DE CRESCENZO, G., MARINO, D.&MARONE, G. (1997) Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. Arthritis and Rheumatism 40, 469-478
10. DUNCAN, J. I. (1994) Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin. Journal of Investigative Dermatology 102, 84-88
11. DUPUY, P., BAGOT, M., MICHEL, L., DESCOURT, B.&DUBERTRET, L. (1991) Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. Journal of Investigative Dermatology 96, 408-413
12. EZEAMUZIE, I. C.&ASSEM, E. S. (1990) Inhibition of histamine release from human lung and rat peritoneal mast cells by cyclosporin-A. Agents and Actions 30, 110-113
13. FURUE, M.&KATZ, S. I. (1988) The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro. Journal of Immunology 140, 4139-4143
14. GARCIA, G., FERRER, L., DEMORA, F.&PUIGDEMONT, A. (1998) Inhibition of histamine release from dispersed canine mast cells by cyclosporin A, rolipram and salbutamol, but not by dexamethasone or sodium cromoglycate. Veterinary Dermatology 9, 81-86
15. GARCIA, J.E., LOPEZ, A.M., DE CABO, M. R., RODRIGUEZ, F. M., LOSADA, J. P., SARMIENTO, R. G., LOPEZ, A. J.&ARELLANO, J. L. (1999) Cyclosporin A decrease human macrophage interleukin-6 synthesis at a post transcriptional level. Mediators of Inflammation 8, 253-259
16. HATFIELD, S. M.&ROEHM, N. W. (1992) Cyclosporine and FK506 inhibition of murine mast cell cytokine production. Journal of Pharmacology and Experimental Therapeutics 260, 680-688
17. IVERSEN L., SVENDSEN, M.&KRAGBALLE, K. (1996) Cyclosporin A down-regulates the LTA4 hydrolase level in human keratinocyte cultures. Acta Dermato-Venereologica 76, 424-428
18. ITO, F., TOYOTA, N., SAKAI, H., TAKAHASHI, H.&IIZUKA, H. (1999) FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducin upregulation of c-kit expression in cells of the mast cell line MC/9. Archives of Dermatological Research 291, 275-283
19. KANITAKIS, J.&THIVOLET, J. (1990) Cyclosporine. An immunosuppressant affecting epithelial cell proliferation. Archives of Dermatology 126, 369-375
20. KAPLAN, A., MATSUE, H., SHIBAKE, A., KAWASHIMA, T., KOBAYASHI, H.&OHKAWARA, A. (1995) Effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes. Journal of Dermatological Science 10, 130-138
21. KARASHIMA, T., HACHISUKA, H.&SASAI, Y. (1996) FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle. Journal of Dermatological Science 12, 246-254
22. KHANDKE, L., KRANE, J. F., ASHINOFF, R., STAIANO-COICO, L., GRANELLI-PIPERNO, A., LUSTER, A. D., CARTER, D. M., KRUEGER, J. G. & GOTTLIEB, A. B. (1991) Cyclosporine in psoriasis treatment. Inhibition of keratinoctye cell-cyle progession in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways. Archives of Dermatology 127. 1172-1179
23. LEBEL, B., CRAMPETTE, L., VERGNES, C., CAMPBELL, A. M. & BOUSQUET, J. (1998) Inhibition of mediator release from dispersed nasal polyp cells by cyclosporin A. International Archives of Allergy and Immunology 116, 284-287
24. MARONE, G., TRIGGIANI, M. CIRILLO, R., GIACUMMO, A., SIRI, L. &CONDORELLI, M. (1988) Cyclosporin A inhibits the release of histamine and peptide leukotrine C4 from human lung mast cells. Ricerca in Clinica e in Laboratorio 18. 53-59
25. MARSELLA, R.&OLIVRY, T. (2001) The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy. Veterinary Immunology and Immunopathology 81, 331-345
26. MEG, Q., YING, S., CORRIGAN, C. J., WAKELIN, M., ASSOUFI, B., MOQBEL, R.&KAY, A. B. (1997) Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Allergy 52, 1095-1101
27. MISRA, U. K., GAWDI, G.&PIZZO, S. V. (1998) Cyclosporin A inhibits inositol 1,4,5-triphosphate binding to its receptors and release of calcium from intracellular stores in peritoneal macrophages. Journal of Immunology 161, 6122-6127
28. MITCHELL, R. W., COZZI, P., NDUKWU, I. M., SPAETHE, S., LEFF, A. R.&PADRID, P. A. (1998) Differential effects of cyclosporine A after acute antigen challenge in sensitised cats in vivo and ex vivo. British Journal of Pharmacology 123, 1198-1204
29. PANYI, G., GASPAR, R., KRASZNAI, Z., TER HORST, J. J., AMELOOT, M., ASZALOS, A., STEELS, P.&DAMJANOVICH, S. (1996) Immunosuppressors inhibit voltage-gated potassium channels in human peripheral blood lymphocytes. Biochemical and Biophysical Research Communications 221, 254-258
30. PAPICH, M. G. (1998) Immunosuppressive drug therapy. In Proceedings of the 14th Annual Members Meeting of the American Association of Veterinary Dermatolgy and the American College of Veterinary Dermatology, Concurrent Session Notes. San Antonio, Texas, USA, April 16 to 19. pp 41-48
31. PETRI, J. B., SCHURK, S., GEBAUER, S.&HAUSTEIN, U. F. (1998) Cyclosporine A delays wound healing and apoptosis and suppresses activin beta-A expression in rats. European Journal of Dermatology 8, 104-113
32. PRENS, E. P., VAN JOOST, T., HEGMANS, J., THOOFT-BENNE, K., YSSEL-MUIDEN, O.E.&BENNER, R. (1995) Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. Journal of the American Academy of Dermatology 33, 947-953
33. RAFIQ, K., CHARITIDOU, L., BULLENS, D. M., KASRAN, A., LORRE, K., CEUPPENS, J.&VAN GOOL, S. W. (2001) Regulation of the IL-10 production by human T cells. Scandinavian Journal of Immunology 53, 139-147
34. READ, R. A. (1996) Cyclosporin and its treatment of ophthalmic diseases in animals. Australian Veterinary Practitioner 26, 86-91
35. ROSENKRANTZ, W. S., GRIFFIN, C. E.&BARR, R. J. (1989) Clinical evaluation of cyclosporine in animal models with cutaneous immune-mediated disease and epitheliotropic lymphoma. Journal of the American Animal Hospital Association 250, 377-384
36. SCAVUZZO, M., SAGRIPANTI, A., MOSCA, F.&AMBROGI, F. (2001) Modulation of beta2 integrin phenotype, adhesion, chemotaxis, and oxidative burst of neutrophils by cyclosporine. Biomedicine and Pharmacotheraphy 55, 61-69
37. SEIBEL, W., SUNDBERG, J. P., LESKO, L. J., SAUK, J. J., MCCLEARY, L. B.&HASSELL, T. M. (1989a) Cutaneous papillomatous hyperplasia in cyclosporine-A treated beagles. Journal of Investigative Dermatology 93, 224-230
38. SEIBEL, W., YAHIA, N. A., MCCLEARY, L. B. LESKO, L. J. & HASSELL, T.M . (1989b) Cyclosporine-induced gingival overgorwth in beagle dogs. Journal of Oral Pathology and Medicine 18, 240-245
39. 2+ uptake into the endoplasmic reticulum and mitochondria. Journal of Biological Chemistry 276, 23, 329-23,340
40. SÖDERLUND, T., LEHTONEN, J. Y.&KINNUNEN, P. K. (1999) Interactions of cyclospron A with phospholipid membranes: effect of cholesterol. Molecular Pharmacology 55, 32-38
41. STELLATO, C., DE PAULIS, A., CICCARELLI, A., CIRILLO, R., PATELLA, V., CASOLARO, V.&MARONE, G. (1992) Anti-inflammatory effect of cyclosporin A with phspholipid membranes: effect of cholesterol. Molecular Pharmacology 55, 32-38
42. STELLATO, C., DE PAULIS, A., CICCARELLI, A., CIRILLO, R., PATELLA, V., CASOLARO, V.&MARONE, G. (1992) Anti-inflammatory effect of cyclosporin A on human skin mast cells. Journal of Investigative Dermatology 98, 800-804
43. TOYODA, M., NAKAMURA, M.&MOROHASHI, M. (2002) The modulation of neuropeptides with cyclosporin A and PUVA therapy in atopic dermatitis (Abstract). Annales de Dermatologie et de Vénéréologie 129, 1S331
44. VADEN, S. L. (1997) Cyclosporin and tacrolimus. Seminars in Veterinary Medicine and Surgery (Small Animal) 12, 161-166
45. VIOLA, J. P.&RAO, A. (1997) Role of the cyclosporine-sensitive transcription factor NFAT1 in the allergic response (Abstrat). Memorias Do Instituto Oswaldo Cruz 92 (Suppl 2), 147-155
46. WON, Y. H., SAUNDER, D. N.&MCKENZIE, R. C. (1994) Cyclosporin A inhibits keratinocyte gene expression. British Journal of Dermatology 130, 312-319
47. WONG, R. L., WINSLOW, C. M.&COOPER, K. D. (1993) The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunology Today 14, 69-74